Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)

Por Baldini, E, Ardizzoni, A, Prochilo, T, Cafferata, M A, Boni, L, Tibaldi, C, Neumaier, C, Conte, P F, Rosso, R
Publicado em 2001

Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study

Por Tibaldi, C, Prochilo, T, Russo, F, Pennucci, M C, Del Freo, A, Innocenti, F, Fabbri, A, Falcone, A, Conte, P F, Baldini, E
Publicado em 2006

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Canc...

Por Ardizzoni, A., Addamo, G. F., Baldini, E., Borghini, U., Portalone, L., De Marinis, F., Lionetto, R., Conte, P. F., Bruzzi, P., Pennucci, M. C.
Publicado em 1995

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

Por Baldini, E, Prochilo, T, Salvadori, B, Bolognesi, A, Aldrighetti, D, Venturini, M, Rosso, R, Carnino, F, Gallo, L, Giannessi, P, Conte, P F, Orlandini, C, Bruzzi, P
Publicado em 2004

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Por Sugarbaker, D J, Garcia, J P, Richards, W G, Harpole, D H, Healy-Baldini, E, DeCamp, M M, Mentzer, S J, Liptay, M J, Strauss, G M, Swanson, S J
Publicado em 1996

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Por Tiseo, M, Bordi, P, Bortesi, B, Boni, L, Boni, C, Baldini, E, Grossi, F, Recchia, F, Zanelli, F, Fontanini, G, Naldi, N, Campanini, N, Azzoni, C, Bordi, C, Ardizzoni, A
Publicado em 2013

Corrigendum: Femtosecond X-ray absorption study of electron localization in photoexcited anatase TiO(2)

Por Santomauro, F. G., Lübcke, A., Rittmann, J., Baldini, E., Ferrer, A., Silatani, M., Zimmermann, P., Grübel, S., Johnson, J. A., Mariager, S. O., Beaud, P., Grolimund, D., Borca, C., Ingold, G., Johnson, S. L., Chergui, M.
Publicado no Sci Rep (2016)

Femtosecond X-ray absorption study of electron localization in photoexcited anatase TiO(2)

Por Santomauro, F. G., Lübcke, A., Rittmann, J., Baldini, E., Ferrer, A., Silatani, M., Zimmermann, P., Grübel, S., Johnson, J. A., Mariager, S. O., Beaud, P., Grolimund, D., Borca, C., Ingold, G., Johnson, S.L., Chergui, M.
Publicado no Sci Rep (2015)

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial tr...

Por Boni, C, Tiseo, M, Boni, L, Baldini, E, Recchia, F, Barone, C, Grossi, F, Germano, D, Matano, E, Marini, G, Labianca, R, Di Costanzo, F, Bagnulo, A, Pennucci, C, Caroti, C, Mencoboni, M, Zanelli, F, Prochilo, T, Cafferata, M A, Ardizzoni, A
Publicado em 2012

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONIC...

Por Baldini, E., Tibaldi, C., Ardizzoni, A., Salvati, F., Antilli, A., Portalone, L., Barbera, S., Romano, F., De Marinis, F., Migliorino, M. R., Noseda, M. A., Borghini, U., Crippa, M., Ferrara, G., Raimondi, M., Fioretti, M., Bandera, M., Pennucci, M. C., Galeasso, G., Cacciani, G. C., Lepidini, G., Sunseri, G., Lanfranco, C., Rinaldi, M., Rosso, R.
Publicado em 1998